Literature DB >> 24904002

Increased prevalence of psoriasis in patients with coronary artery disease: results from a case-control study.

D Picard1, J Bénichou, C Sin, C Abasq, E Houivet, R Koning, A Cribier, B Veber, F Dujardin, H Eltchaninoff, P Joly.   

Abstract

BACKGROUND: The incidence of myocardial events has been reported to be increased in patients with psoriasis.
OBJECTIVES: To investigate whether psoriasis is an independent risk factor for coronary artery disease (CAD).
METHODS: We compared the prevalence of psoriasis between case patients with a diagnosis of CAD based on coronary angiography findings and control patients with no CAD referred to the emergency surgery department for an acute noncardiovascular condition. Case and control patients were examined for the presence of psoriasis by two dermatologists. The prevalence of psoriasis was compared among patients with CAD according to CAD severity. Five-hundred cases and 500 age- and sex-matched controls were included.
RESULTS: Using matched univariate analysis, the prevalence of psoriasis was about twofold higher in CAD case patients than in control patients [8·0% vs. 3·4%, odds ratio (OR) 2·64; 95% confidence interval (CI) 1·42-4·88]. Using unconditional multivariate analysis, the association of psoriasis with CAD appeared to be borderline significant (OR 1·84; 95% CI 0·99-3·40). Psoriasis in patients with CAD was significantly associated with three-vessel involvement relative to one-or two-vessel involvement (13·1% vs. 6·1%; OR 3·07; 95% CI 1·50-6·25).
CONCLUSIONS: The prevalence of psoriasis is twofold higher in patients with CAD than in control patients without CAD. It is associated with a more severe coronary artery involvement.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2014        PMID: 24904002     DOI: 10.1111/bjd.13155

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.

Authors:  Sayaka Shibata; Yayoi Tada; Carren Sy Hau; Aya Mitsui; Masahiro Kamata; Yoshihide Asano; Makoto Sugaya; Takafumi Kadono; Yosuke Masamoto; Mineo Kurokawa; Toshimasa Yamauchi; Naoto Kubota; Takashi Kadowaki; Shinichi Sato
Journal:  Nat Commun       Date:  2015-07-15       Impact factor: 14.919

2.  The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.

Authors:  Peter M Mihailovic; Wai Man Lio; Juliana Yano; Xiaoning Zhao; Jianchang Zhou; Kuang-Yuh Chyu; Prediman K Shah; Bojan Cercek; Paul C Dimayuga
Journal:  PLoS One       Date:  2017-11-01       Impact factor: 3.240

Review 3.  Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.

Authors:  Stephen Chu-Sung Hu; Cheng-Che E Lan
Journal:  Int J Mol Sci       Date:  2017-10-21       Impact factor: 5.923

Review 4.  The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis.

Authors:  A Egeberg; P Gisondi; J M Carrascosa; R B Warren; U Mrowietz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-15       Impact factor: 6.166

5.  Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease.

Authors:  Peng-Fei Zheng; Lu-Zhu Chen; Yao-Zong Guan; Peng Liu
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

6.  Prevalence of Atherosclerosis in Psoriatic Patients Detected with Epiaortic Color Doppler Ultrasound and Computed Tomography Angiography.

Authors:  Annunziata Dattola; Guglielmo Manenti; Donatella Ferrari; Laura Vollono; Salvatore Marsico; Feliciana Lamacchia; Maria Esposito; Mattia Marchesano; Arianna Zangrilli; Roberto Floris; Alessandro Giunta; Luca Bianchi
Journal:  Dermatol Pract Concept       Date:  2022-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.